Learn more

THEURER KARL EUGEN

Overview
  • Total Patents
    15
About

THEURER KARL EUGEN has a total of 15 patent applications. Its first patent ever was published in 1981. It filed its patents most often in Germany and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are COPERNICUS THERAPEUTICS INC, KARL THEURER DR MED and INTEROLIGO CORP.

Patent filings in countries

World map showing THEURER KARL EUGENs patent filings in countries
# Country Total Patents
#1 Germany 8
#2 EPO (European Patent Office) 7

Patent filings per year

Chart showing THEURER KARL EUGENs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Theurer Karl Eugen Prof Dr Med 10
#2 Theurer Karl E Prof Dr Med 4
#3 Theurer Karl Georg Dr Med 1
#4 Eugen Prof Dr Med Theurer Karl 1

Latest patents

Publication Filing date Title
EP0485652A1 Process to prepare vaccines against pathologic agents
DE3744785A1 Use of retrograde mirror-image antisense nucleic acids against cancers
DE3546452A1 FILLING OF MEDICINAL PRODUCTS AND DIETS CONTAINING HONEY OR SUGAR SUBSTANCES
DE3509153C1 Method for the immunological sensitisation of parts of a permanently cultivated, non-sensitised cell line of malignant cells of the immune system or of hybridoma cells
EP0161404A2 Process for the preparation of artificial biomimetic haptens or antigens
DE3441764A1 Process for the production of toxins which are formed after burns and/or effects of radiation or after chemical noxia
DE3437757A1 Process for the preparation of artificial biomimetic haptens and antigens
EP0162129A1 Preparation of pharmaceutical and dietetic compositions from milk, cream or butter fat, and their use
EP0164423A2 Carriers and additives for biologically active or regulatory factors from cells and tissues, and their use
DE3339907A1 Preparation and therapeutic use of liposome membranes with cytotropism
DE3302319A1 A method for the preservation, stabilisation and improvement of the absorption of cell and organ constituents to be used for therapy
EP0083673A1 Products for intravasal application of water-soluble or emulsifiable antigenic organ extracts
EP0049341A2 Process for conditioning alloplastic implantations and transplantations
EP0070328A1 Use of egg membranes and umbilical cord in unmodified or modified form